Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific’s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution.
Specific’s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific’s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections.
Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.
Specific is located in Mountain View, California.
For more information, visit www.specificdx.com.
Corporate Contact, email: press@specificdx.com
Location: United States, California, Mountain View
Employees: 51-200
Total raised: $15.4M
Founded date: 2011
Investors 1
Date | Name | Website |
- | Telegraph ... | thpartners... |
Funding Rounds 2
Date | Series | Amount | Investors |
02.06.2020 | - | $2.9M | - |
06.09.2019 | - | $12.5M | - |
Mentions in press and media 6
Date | Title | Description | Source |
05.04.2022 | Specific Diagnostics Invited to Present at the William Blair... | SPECIFIC REVEAL® Rapid AST System “We anticipate and look forward to a productive exchange of inform... | prweb.com/... |
14.02.2022 | Specific Diagnostics Invited to Present at the BTIG Virtual ... | Specific Reveal® Rapid AST System “We are pleased to share our story with public company investors a... | prweb.com/... |
29.06.2021 | bioMérieux and Specific Diagnostics announce a co-exclusive ... | “Every lab we encounter wants rapid, easy-to-use susceptibility testing at the right price; we could... | prweb.com/... |
02.06.2020 | Specific Diagnostics Announces that NIAID has Awarded the Co... | MOUNTAIN VIEW, California, June 2, 2020 – Specific Diagnostics today announces that the National Ins... | thpartners... |
06.09.2019 | Specific Diagnostics Receives $12.5M Investment | MOUNTAIN VIEW, CA, Specific Diagnostics today announced an investment of $12.5M by Telegraph Hill ... | vcnewsdail... |
06.09.2019 | Specific Diagnostics Receives Investment from Telegraph Hill... | Specific Diagnostics, a Mountain View, CA-based developer of in vitro diagnostic systems for the det... | finsmes.co... |